Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 4/2002

01-12-2002 | ORIGINAL

Secretory defects induced by immunosuppressive agents on human pancreatic β-cells

Authors: L. Polastri, F. Galbiati, F. Bertuzzi, P. Fiorina, R. Nano, S. Gregori, L. Aldrighetti, G. Pozza, A. Secchi, L. Adorini, A.M. Davalli

Published in: Acta Diabetologica | Issue 4/2002

Login to get access
Metadata
Title
Secretory defects induced by immunosuppressive agents on human pancreatic β-cells
Authors
L. Polastri
F. Galbiati
F. Bertuzzi
P. Fiorina
R. Nano
S. Gregori
L. Aldrighetti
G. Pozza
A. Secchi
L. Adorini
A.M. Davalli
Publication date
01-12-2002
Publisher
Springer-Verlag Italia
Published in
Acta Diabetologica / Issue 4/2002
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s005920200039

Other articles of this Issue 4/2002

Acta Diabetologica 4/2002 Go to the issue

ORIGINAL

Decrease in the insulin receptor protein level by anti-insulin receptor antibodies: roles of tyrosine kinase activity and receptor internalization

ORIGINAL

Hypocalcemia reduces insulin turnover but not insulin-mediated glucose metabolism in piglets

ORIGINAL

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes

ORIGINAL

Low serum magnesium levels and metabolic syndrome

CASE REPORT

Association between diabetic ketoacidosis and thyrotoxicosis

ORIGINAL

Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits